Some specialties, like oncology, have been quicker to embrace the promise of pharmacogenomics (PGx), and their successes can serve as a roadmap as others explore the impact it can have on quality, outcomes and patient satisfaction.

The post PGx Testing: Specialists Benefit From, and Build Upon Oncology’s Success appeared first on MedCity News.

Tampa General Hospital is launching a virtual cancer care program with Reimagine Care. The partnership seeks to support cancer patients between visits and reduce avoidable emergency care, as well as reduce oncologists’ administrative burden.

The post Tampa General Adopts New Oncology Model to Ease Clinician Workload & Improve Patient Outcomes appeared first on MedCity News.

Theranostics — which combines molecular imaging with targeted therapy — is quickly becoming a significant innovation in cancer care, offering more precise treatment with fewer side effects. GE Healthcare expects the field to grow rapidly over the next decade, as long as hospitals can continue to invest in the imaging and software infrastructure needed to scale these therapies.

The post Theranostics Could Transform Cancer Care, GE Healthcare Leader Says appeared first on MedCity News.

Genomic technologies not only help to identify cancers, but also offer opportunities for assessing the potential efficacy of different treatment options. By analyzing the genomic profile of a particular patient, doctors can see which medications might offer the most support, and which could cause more harm.

The post Oncologists Turn To Genomics For Improved Answers appeared first on MedCity News.

[Sponsored] For non small cell lung cancer patients, a zip code can mean the difference between diagnosis time and treatment options.

The post SDOH in Oncology: Mapping Out How Zip Code Can Affect Care Is a Critical Step to Improving Outcomes appeared first on MedCity News.

A growing body of evidence shows that structured lifestyle interventions such as physical activity, nutrition, and stress management aren’t just helpful; they also reduce cancer recurrence, improve quality of life, lower mortality, and even decrease healthcare costs. 

The post It’s Time to Make Lifestyle Interventions Standard in Oncology appeared first on MedCity News.

[Sponsored] In this latest episode, Arundhati explores how one Mayo Clinic doctor found purpose in her deeply personal tragedy and how Mayo Clinic Florida then took her idea, executed on it and is attempting to scale it.

The post MedCity Pivot Podcast: Mayo Clinic Florida Redefines Cancer Care appeared first on MedCity News.

This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources.

The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared first on MedCity News.

Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of Clinical Oncology in Chicago. We covered that news and other developments from the largest cancer conference in the world.

The post ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More appeared first on MedCity News.

Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients.

The post MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? appeared first on MedCity News.

Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers.

The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.

Breast cancer survivor Kate Dilligan is the CEO of Cooler Heads, a company that sells a portable and self-administered scalp cooling device. The system helps chemotherapy patients retain their hair, and therefore their self-esteem and privacy.

The post ‘It’s Not About Beauty, It’s About Privacy’: How One Cancer Survivor Is Changing Chemo Care appeared first on MedCity News.

Radiotherapy, China’s biotech surge and AI’s role in drug discovery are notable topics that emerged from conversations on the ground floor.

The post Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference appeared first on MedCity News.

China has become a key piece of Foresite Capital’s investment and company formation strategy. During the J.P. Morgan Healthcare Conference, Managing Director Michael Rome shared his thoughts on why biotech in China is booming as well as therapeutic areas where he sees promising science.

The post VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology appeared first on MedCity News.

Memorial Hermann Health System and Moffitt Cancer Center have recently struck partnerships with Reimagine Care, a startup focused on providing support to cancer patients via an AI assistant and text messages with oncology experts.

The post Health Systems Are Partnering with Reimagine Care to Improve Cancer Treatment appeared first on MedCity News.

The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.

The post Why Cancer Centers of Excellence May Not Be Right for Every Patient appeared first on MedCity News.

My phone chimed with a notification, signaling the availability of a new CT test result in my online health portal. “Multiple bilateral pulmonary nodules measuring up to 8mm. May represent metastatic disease.” This was several weeks after my very first mammogram–which I underwent shortly after my 40th birthday–detected an anomaly on my left breast. I […]

The post I Used AI Tech To Find My Own Cancer Clinical Trial, and You Can Too appeared first on MedCity News.

[Sponsored] A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.

The post Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health appeared first on MedCity News.

OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.

The post Why OneOncology Is Adopting Verily’s Clinical Trial Management System appeared first on MedCity News.

CMS’ Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.

The post Cancer Moonshot: Would It Even Be Possible in Today’s Fee-For-Service World? appeared first on MedCity News.

Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund’s founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.

The post VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care appeared first on MedCity News.

Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi’s protégé writes why her research is so important.

The post What A Nobel Prize-Winner’s Research Means for Cancer Treatment appeared first on MedCity News.

Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.

The post Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance appeared first on MedCity News.

Cancer is a serious public health issue, accounting for nearly 10 million deaths and over 19 million new cancer cases around the world in 2020. The WHO estimates that the number of new cancer cases will increase to nearly 29 million in 2040. This alarming statistic is indicative of the huge focus and investment that […]

The post Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey appeared first on MedCity News.

Fewer people are dying from cancer due to advances in research, screening and treatment, according to a new report. In order for the death rate to fall further, U.S. oncologists must prioritize personalized treatment and addressing social determinants of health, an expert argued.

The post The cancer death rate is falling — focusing on equity and personalization will help it drop further appeared first on MedCity News.

Strata Oncology partnered with UW Health to integrated its next generation sequencing tumor profiling test into the health system’s Epic EHR. Being able to order the test and see its results from within the EHR will help UW clinicians more efficiently leverage genomic findings into their precision oncology treatment plans.

The post Strata, UW Health team up to bring genomic testing to more cancer patients appeared first on MedCity News.

Ochsner Health added a tool to its Epic EHR that allows physicians to seamlessly order genomics tests and view results within the EHR. The integration will allow physicians to provide more personalized and effective care now that they can have a single view of their patients’ genomic and clinical data in one place. The news comes two months after MU Health Care added a similar tool into its Oracle Cerner EHR.

The post Epic introduces genomic test ordering tool within EHR with Ochsner as first user appeared first on MedCity News.

Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means drug developers may have a new, highly specific target for oncology therapeutics.

The post Biopharma has a brand new target: Cancer-specific collagen appeared first on MedCity News.

[Sponsored] As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence-based programs with the need to manage healthcare costs.

The post Cancer care poses challenges for employers; Transcarent shares vision for how it can help appeared first on MedCity News.

San Francisco-based Blumio and Saint Paul, Minnesota-based NxGenPort tied for the top prize in the Remote Patient Monitoring and Smart Devices track of INVEST Pitch Perfect, the startup competition integral to MedCity News’ INVEST conference. Here is an in-depth look at each company.

The post Judges: Joint winners at INVEST Pitch Perfect’s RPM track address large unmet need, have clear reimbursement path appeared first on MedCity News.